metabolic

(redirected from metabolic defect)
Also found in: Dictionary, Thesaurus, Medical.
Related to metabolic defect: Metabolic diseases, Metabolic disorders

metabolic

[‚med·ə′bäl·ik]
(physiology)
Of or pertaining to metabolism.
References in periodicals archive ?
A total of 71 features differentiated PA from MMA, a finding that is quite remarkable given the very close proximity of the 2 metabolic defects.
DeCherney favors using metformin indefinitely in these patients except during pregnancy because the drug corrects a key underlying metabolic defect in PCOS.
As he was being born at Lucile Packard Children's Hospital, Dean Thao received infusions of a medication -- never before given prenatally -- for a rare metabolic defect that usually causes permanent brain damage, and often death.
The study has a total planned enrollment of approximately 480 patients and is the first of two Phase 3 trials of AC-1204, an investigational new drug designed to address the metabolic defect of the brain observed in Alzheimer's patients.
Even very small doses of the enzyme apparently correct the metabolic defect, reversing some symptoms and, if given early enough, blocking disease progression.
He makes the unorthodox suggestion that sweets may represent a behavior-enhancing compensation for a metabolic defect in some delinquents.
There is a strong and growing body of scientific evidence that Alzheimer's is characterized by a metabolic defect of the brain, and that a nutritional-based drug may prove beneficial.
Combination of gene therapy and hepatocyte (HEP) transplantation is a promising alternative to LT, correcting the metabolic defect while keeping in place the normal native liver.
It appears likely, therefore, that the 5-oxoprolinuria demonstrated in our patient was attributable to a metabolic defect at some stage in the [gamma]-glutamyl cycle and that this resulted in the biochemical and clinical findings.
The data also suggested that the extent and severity of the metabolic defect detected by BMIPP was similar to that identified by thallium blood flow imaging.
ADI-PEG 20 (pegylated arginine deiminase) is a biologic being developed by Polaris Group to treat cancers, especially those carrying a major metabolic defect that renders such cancer cells, unlike normal cells, unable to internally synthesize arginine.